Jubilant, MRF, Hindalco, and other stocks that moved most on November 9
- Jubilant Foodworks shares ended 7.55% lower after reporting 9.8% rise in net profit
- MRF shares ended 8.72% lower after Q2 results
- Hindalco Industries Ltd ended 4.69% lower after US subsidary's quarterly results
Indian equity benchmarks ended lower on Wednesday with the Sensex losing 151.60 or 0.25% to close at 61,033.55 points. The Nifty fell 45.80 or 0.25% to settle at 18,157.00.
The broader indices ended red the BSE MidCap index losing 0.52% and the SmallCap index down by 0.33%. The top losing sectoral indices on the BSE were Realty down by 1.42%, Metal 1.04%, Consumer Durables 1.03%, Healthcare 0.98%, and Consumer Discretionary 0.93%, while Healthcare up by 1.47%, Consumer Durables 0.25%, Consumer Durables 0.22%, and Consumer Durables 0.03% were the gaining sectoral indices on BSE.
Also Read: Gold, silver and other metal prices on Wednesday, November 9, 2022
PI Industries Ltd: The stock ended 9.79% higher at Rs 3,620.00 on the BSE after the company reported a strong 46% year-on-year growth in profit after tax during the second quarter of the financial year 2022-23 at Rs 334.8 crore. EBITDA for the quarter stood at Rs 433.1 crore with a growth of 49% year-on-year. Revenue from operations grew 31% to Rs 1770 crore during the reviewed quarter.
Also Read: Top 5 cryptocurrencies of the day: Bitcoin down 8%, FTX Token trends at no. 1
Bosch Ltd: The stock ended 4.64% higher at Rs 17,224.95 on the BSE after the company reported a net profit of Rs 372.4 crore during the second quarter of the financial year 2022-23, against Rs 372 crore posted in the year-ago corresponding quarter. Revenue from operation stood at Rs 3,661.6 after a growth of 25.5% year-on-year.
Also Read: Twitter set to launch ‘Official’ tag for select accounts
Jubilant Foodworks Ltd: The stock ended 7.55% lower at Rs 566.45 on the BSE after the company reported a 9.8% rise in net profit at Rs 131.5 crore for the second quarter of the financial year 2022-23, against Rs 119.8 crore during the corresponding quarter last fiscal. Revenue from operations grew by 16.6% to Rs 1,301.5 crore, against Rs 1,116.2 crore in the year-ago quarter.
Also Read: Central Bank of Russia explores crypto’s place in financial system
Hindalco Industries Ltd: The stock ended 4.69% lower at Rs 417.00 on the BSE after the company’s US subsidiary Novelis’ reported weak quarterly performance. Novelis’ posted a 23% decline in net profits to $183 million for the second quarter of the financial year 2022-23, against $237 million in the year-ago quarter. Net sales of the company stood at $4,799 million against $4,119 million in the year-ago quarter. EBITDA declined 8% year-on-year to $506 million.
Also Read: Six years after demonetisation, Indians have highest-ever cash in hand
MRF Ltd: The stock ended 8.72% lower at Rs 86,645.00 on the BSE after the company reported a 32% year-on-year decline in net profit to Rs 124 crore for the second quarter of the financial year 2022-23, against Rs 183 crore in the year-ago quarter. Revenue from operations jumped 18.4% to Rs 5,719 crore year-on-year, against Rs 4,831 crore.
Also Read: Meta, parent company of Facebook, planning first major layoff in its history: Report
Affle (India) Ltd: The stock ended 3.14% higher at Rs 1,190.50 on the BSE after the company reported a 39.6% year-on-year rise in profit at Rs 58.7 crore for the second quarter of the financial year 2022-23. Revenue stood at Rs 354.6 crore rose 29% year-on-year and EBITDA rose 39% year-on-year to Rs 72.3 crore during the reviewed quarter.
Also Read: Twitter delays launch of $8 subscription plan for blue ticks until end of midterms: Report
Ceat Ltd: The stock ended 5.53% higher at Rs 1,704.00 on the BSE after the company reported an 85% year-on-year decline in consolidated profit at Rs 6.44 crore for the second quarter of the financial year 2022-23. Revenue from operations rose 18% year-on-year to Rs 2,894 crore, and EBITDA stood at Rs 203.14 crore declining 7.8% from the year-ago quarter.
Related Articles
ADVERTISEMENT